ロード中...
Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western populations, and is closely associated with features of the metabolic syndrome. The burden of disease is set to rise exponentially, and this is further compounded by the lack of good medications. In addition...
保存先:
| 出版年: | Endocrinol Diabetes Metab |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576222/ https://ncbi.nlm.nih.gov/pubmed/33102791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.105 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|